ClinicalTrials.govpublic full text
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
chronic lymphocytic leukemia (cll), chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 871024
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.